Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mesa Laboratories Inc. (MLAB:NASDAQ), powered by AI.
Mesa Laboratories Inc. is currently trading at $99.68. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Mesa Laboratories Inc. on Alpha Lenz.
Mesa Laboratories Inc.'s P/E ratio is -273.7.
“Mesa Laboratories Inc. trades at a P/E of -273.7 (undervalued) with modest ROE of -1.3%.”
Ask for details →Mesa Laboratories Inc. is a diversified manufacturer of critical equipment and software for specialized applications in regulated industries. Its primary function is to develop and produce precision instruments and consumables that ensure quality and safety across a variety of sectors, including healthcare, pharmaceuticals, and food and beverage industries. Notable features of the company include its focus on developing advanced monitoring systems, calibration devices, and sterilization products designed to comply with stringent regulatory standards. Mesa Laboratories plays a significant role in ensuring that the processes within these industries meet and maintain the necessary compliance requirements, which are critical for both product safety and market acceptance. Founded in 1982 and headquartered in Lakewood, Colorado, Mesa Laboratories is recognized for its innovation and reliability, continually expanding its product lines through strategic acquisitions and relentless research and development efforts.
“Mesa Laboratories Inc. trades at a P/E of -273.7 (undervalued) with modest ROE of -1.3%.”
Ask for details →Mesa Laboratories Inc. (ticker: MLAB) is a company listed on NASDAQ in the Technology sector (Scientific & Technical Instruments). It has approximately 730 employees. Market cap is $540M.
The current price is $99.68 with a P/E ratio of -273.74x and P/B of 3.38x.
ROE is -1.29% and operating margin is 6.78%. Annual revenue is $241M.